Smoking Termination Opportunity for inPatients (STOP)
Wednesday, November 7, 2012
Posted by: Natalia Gromov
of a Course of Varenicline Tartrate Plus Counseling Over Counseling Alone for
Smoking Cessation: A 12-month Randomized Controlled Trial for Inpatients.
Smith BJ, Carson KV, Brinn
MP, Labiszewski NA, Peters MJ, Fitridge R, Koblar SA, Jannes J, Veale AJ,
Goldsworthy SJ, Litt J, Edwards D, Esterman AJ.
Thorax. 2012 Sep 19. [Epub
ahead of print]
This study examined the effectiveness of varenicline tartrate plus quitline
counseling compared to quitline counseling alone in an inpatient setting.
Participants admitted to one of three hospitals with a smoking-related illness
were randomized to 12-weeks of varenicline plus quitline counseling or quitline
counseling alone, with 12-month follow-up. Results showed that more
participants in the varenicline arm remained continuously abstinent (31.1%)
than in the counseling only arm (21.4%) (p=0.03). The authors conclude that in
an inpatient hospital setting, the combined use of varenicline plus quitline
counseling can produce a successful opportunistic treatment for smokers
admitted with smoking related illness.